Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,058 public trials 714 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Recruiting

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

NCT07662044

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Daphne, Alabama, United States
  • Research Site Lomita, California, United States
  • Research Site Los Alamitos, California, United States
  • Research Site San Diego, California, United States
View all 149 locations
View Trial Details
Recruiting

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

NCT07662109

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Mobile, Alabama, United States
  • Research Site Sheffield, Alabama, United States
  • Research Site Little Rock, Arkansas, United States
View all 272 locations
View Trial Details
Recruiting

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

NCT07564414

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
Locations
  • Uni of Alabama at Birmingham Birmingham, Alabama, United States
  • Cahaba Research Pelham, Alabama, United States
  • Elligo Health Research Inc Gilbert, Arizona, United States
  • Velocity Clinical Research-Phoenix Phoenix, Arizona, United States
View all 303 locations
View Trial Details
Recruiting

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

NCT06704672

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
Locations
  • Centrum Badań Klinicznych PI-House sp. z o.o. Gdansk, Poland
  • Diabetes Technology Center, Jagiellonian University Medical College Krakow, Poland
  • NZOZ Neuromed Kraśnik, Poland
  • NZOZ Neuromed Lublin, Poland
View all 19 locations
View Trial Details
Recruiting

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

NCT07599982

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +10 more
Locations
  • Henry Ford Health System Detroit, Michigan, United States
  • SUNY Upstate Medical Center Albany, New York, United States
  • Texas Diabetes & Endocrinology Austin, Texas, United States
  • Diabetes & Endocrine Treatment Specialisits (DETS) Sandy City, Utah, United States
View Trial Details
Recruiting

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

NCT07606066

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Little Rock, Arkansas, United States
  • Research Site Lincoln, California, United States
  • Research Site Lake City, Florida, United States
  • Research Site Ocoee, Florida, United States
View all 76 locations
View Trial Details

Related conditions